Dec 2023 An Overview of Testing Capabilities to Identify Use of Marijuana (THC) and Other Natural Cannabinoids
Following the passing of the 2018 Agriculture Improvement Act (a.k.a. Farm Bill), the cannabis industry has seen widespread growth in...
Clinical Update
Nov 2023 Synthetic Stimulants
Novel Psychoactive Substances (NPS) are a diverse group of synthetic substances created to mimic the effects of scheduled or illicit...
Sep 2023 Designer Benzodiazepines
Designer benzodiazepines (DZBDs) represent a major public health issue and their prevalence has increased substantially over the last decade.1 Slight...
Aug 2023 Synthetic Cannabinoids
Novel Psychoactive Substances (NPS) are a diverse group of synthetic substances created to mimic the effects of prescription or illicit...
Nov 2022 Aegis’s Novel Psychoactive Substances Testing Menu Update
In September, Aegis updated both urine and oral fluid novel psychoactive substance (NPS) test menus as a continued commitment to...
Jul 2022 Novel Psychoactive Substances (NPS): What’s New in 2022
Novel Psychoactive Substances (NPS) are a diverse group of synthetic substances created to mimic the effects of scheduled or illicit...
